Skip to main content

Table 1 Baseline characteristics

From: Prognostic model based on the geriatric nutritional risk index and sarcopenia in patients with diffuse large B-cell lymphoma

 GNRI/sarcopenia riskP
High cachexia risk (n = 71)Low cachexia risk (n = 157)
Median age (range), years70 (27–88)59 (21–86)<  0.001
  ≤ 6013 (18.3)83 (52.9)<  0.001
  > 6058 (81.7)74 (47.1) 
Sex  0.111
 Male46 (64.8)84 (53.5) 
 Female25 (35.2)73 (46.5) 
ECOG PS  <  0.001
 0–133 (46.5)131 (83.4) 
 2–338 (53.5)26 (16.6) 
B-symptoms  <  0.001
 Absent46 (64.8)138 (87.9) 
 Present25 (35.2)19 (12.1) 
Bulky disease  0.009
 Non-bulky52 (73.2)137 (87.3) 
 Bulky19 (26.8)20 (12.7) 
Ann Arbor stage  <  0.001
 I – II17 (23.9)83 (52.9) 
 III – IV54 (76.1)74 (47.1) 
Extranodal disease  0.007
 Absent17 (23.9)67 (42.7) 
 Present54 (76.1)90 (57.3) 
LDH  0.005
 Normal19 (26.8)73 (46.5) 
 Elevated52 (73.2)84 (53.5) 
IPI  <  0.001
 Low to Low-intermediate19 (26.8)107 (68.2) 
 High-intermediate to High52 (73.2)50 (31.9) 
NCCN-IPI  <  0.001
 Low to Low-intermediate11 (15.5)95 (60.5) 
 High-intermediate to High60 (84.5)62 (39.5) 
Cell-of-origin (n = 135)  0.421
 GCB10 (23.3)16 (17.4) 
 Non-GCB33 (76.7)76 (82.6) 
Median BMI (range), kg/m221.7 (15.6–29.8)23.9 (15.1–33.7)<  0.001
  1. Data are presented as number of patients (%) except median age and BMI
  2. Abbreviations: GNRI Geriatric Nutritional Risk Index, ECOG PS Eastern Cooperative Oncology Group performance status, LDH lactate dehydrogenase, IPI International Prognostic Index, NCCN-IPI National Comprehensive Cancer Network-International Prognostic Index, GCB germinal center B-cell, BMI body mass index